HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monoclonal antibody B72.3 reacts with a core region structure of O-linked carbohydrates.

Abstract
Monoclonal antibody (moAb) B72.3 appears to be exceptional among the many mouse moAbs reactive with human tumor cells in its degree of tumor specificity. The antigen recognized was characterized as a mucin-like molecule. We report here that B72.3 reacts strongly with ovine submaxillary mucin and that reactivity is abolished by desialylation, suggesting that the determinant recognized is the disaccharide N-acetylneuraminic acid alpha (2----6)-N-acetylgalactosamine, linked to serine or threonine, which might be designated sialylated Tn. A variety of human mucin preparations, including human salivary mucins, and other glycoproteins containing O-linked or N-linked carbohydrates were nonreactive. The data suggest that the determinant recognized is a core structure which is normally not exposed due to chain elongation at C-3 of the N-acetylgalactosamine, which appears to be less frequent in carcinoma cells than in normal cells.
AuthorsD V Gold, M J Mattes
JournalTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (Tumour Biol) Vol. 9 Issue 2-3 Pg. 137-44 ( 1988) ISSN: 1010-4283 [Print] Netherlands
PMID3399812 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Antigens, Tumor-Associated, Carbohydrate
  • Carbohydrates
  • Glycoproteins
  • Mucins
  • Tn antigen
  • Pronase
Topics
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antigens, Neoplasm (analysis, immunology)
  • Antigens, Tumor-Associated, Carbohydrate
  • Carbohydrates (immunology)
  • Cattle
  • Glycoproteins (analysis)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mucins (analysis, immunology)
  • Pronase (pharmacology)
  • Sheep

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: